Singular Genomics Systems In
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 23 superinvestors own shares of Singular Genomics Systems In (OMIC), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Singular Genomics Systems In (OMIC), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Singular Genomics Systems In (OMIC) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Singular Genomics Systems In (OMIC) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Ashley Grim@Vanguard Group Inc
| 0.01% | $978,091 62,418 shares@ 15.68 avg price | Increased 0.01% |
Laura Doherty@Geode Capital Management, Llc
| 0.01% | $281,541 17,962 shares@ 15.68 avg price | Increased 7.12% |
Andres Ortiz@Bank Of America Corp De
| 0.01% | $5,782 369 shares@ 15.67 avg price | Increased 0.55% |
Michael T. Lees@Jpmorgan Chase & Co
| 0.01% | $5,642 360 shares@ 15.68 avg price | Increased 800% |